Cardiotoxicity associated with immune checkpoint inhibitors in cutaneous oncology. [electronic resource]
Producer: 20201110Description: 986-994 p. digitalISSN:- 1097-6787
- Antibodies, Monoclonal, Humanized -- adverse effects
- Antineoplastic Agents, Immunological -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cardiotoxicity -- epidemiology
- Humans
- Incidence
- Ipilimumab -- adverse effects
- Nivolumab -- adverse effects
- Skin Neoplasms -- drug therapy
No physical items for this record
Publication Type: Letter; Review
There are no comments on this title.
Log in to your account to post a comment.